|
Market Closed -
Nasdaq
00:00:00 17/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.470 USD | -1.76% |
|
+11.75% | +292.11% |
| Market Cap | 170M 154M 142M 129M 243M 15.93B 251M 1.71B 678M 8.55B 636M 623M 27.07B | P/E 2026 * |
-5.26x | P/E 2027 * | -5.84x |
|---|---|---|---|---|---|
| Enterprise Value | 112M 102M 93.85M 84.77M 160M 10.5B 166M 1.13B 447M 5.63B 420M 411M 17.85B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
83.44% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ANTX | Delayed | |
| ANTX | Real-time |
Last Transcript: AN2 Therapeutics, Inc.
| 1 day | -1.76% | ||
| 1 week | +11.75% | ||
| Current month | -1.32% | ||
| 1 month | +32.25% | ||
| 3 months | -25.38% | ||
| 6 months | -5.89% | ||
| Current year | +292.11% |
| 1 week | 4.25 | 4.75 | |
| 1 month | 3.21 | 4.9 | |
| Current year | 1 | 7.19 | |
| 1 year | 1 | 7.19 | |
| 3 years | 0.87 | 22.22 | |
| 5 years | 0.87 | 23.58 | |
| 10 years | 0.87 | 23.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 01/02/2017 | |
Eric Easom
CEO | Chief Executive Officer | 58 | 01/11/2019 |
Lucy Day
DFI | Director of Finance/CFO | 67 | 01/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Easom
CHM | Chairman | 58 | 01/06/2024 |
Kabeer Aziz
BRD | Director/Board Member | 36 | 01/11/2019 |
Robin Readnour
BRD | Director/Board Member | 62 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/12/26 A | Free | Director | 389 | 0.0010% | ||
| 10/12/26 A | Free | Director | 2,465 | 0.0065% | ||
| 10/12/26 A | Free | Director | 2,283 | 0.0060% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.76% | +11.75% | +292.11% | -72.79% | 170M | ||
| -1.29% | -3.91% | +51.98% | +69.06% | 65.56B | ||
| -1.98% | -0.46% | +8.56% | +90.18% | 60.41B | ||
| -0.30% | +1.00% | +23.77% | +88.06% | 55.76B | ||
| -1.26% | -1.45% | +12.43% | +117.42% | 46.98B | ||
| -0.15% | -5.06% | +20.00% | +29.27% | 43.63B | ||
| -3.15% | -16.63% | +146.30% | +685.27% | 36.09B | ||
| +0.23% | +2.14% | +14.85% | +46.22% | 36.7B | ||
| -0.71% | -2.12% | +77.42% | +58.10% | 32.9B | ||
| +1.42% | +5.84% | -36.40% | +402.78% | 26.96B | ||
| Average | -0.89% | -0.30% | +61.10% | +151.36% | 41B | |
| Weighted average by Cap. | -0.93% | -1.57% | +34.92% | +150.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -36.42M -33.09M -30.58M -27.62M -52.12M -3.42B -53.95M -368M -146M -1.84B -137M -134M -5.81B | -45.14M -41.01M -37.89M -34.22M -64.58M -4.24B -66.85M -456M -181M -2.27B -169M -166M -7.2B |
| Net Debt | -57.8M -52.51M -48.52M -43.82M -82.7M -5.43B -85.61M -583M -231M -2.91B -217M -212M -9.23B | -31.4M -28.53M -26.36M -23.81M -44.93M -2.95B -46.51M -317M -126M -1.58B -118M -115M -5.01B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | $4.470 | -1.76% | 246,861 |
| 13/11/26 | $4.550 | +2.48% | 205,686 |
| 12/11/26 | $4.440 | -0.45% | 186,344 |
| 11/11/26 | $4.460 | +3.00% | 197,630 |
| 10/11/26 | $4.330 | +8.25% | 271,603 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.470USD
Average target price
9.000USD
Spread / Average Target
+101.34%
- Stock Market
- Stocks
- ANTX Stock
Select your edition
All financial news and data tailored to specific country editions
















